• Accelerator

Detectiome

  • Health
  • Winter 2023
  • Current Member
  • Accelerator

Detectiome

  • Health
  • Winter 2023
  • Current Member

Inventor's story

Detectiome is an AI-multiomics liquid biopsy blood test that can detect most cancers in stage 1 or 2 when they can be treated. It enables fast and economical development of precision diagnosis tailored for the local genetic background as the existing proven technology is developed with non-middle eastern population. The liquid biopsy early cancer detection using cell free DNA methylation is a promising new technique that identifies the cell free DNAs that come from cancer cells and use them for cancer screening and diagnosis.

from UAE

About the founder

1- Dr. Soheil Damangir (Founder & Chief Scientific Officer): 15 years of experience in companies like Grail (Research Director) and Google (Software Engineer) and expertise in creating disruptive AI-based startups. Dr. Soheil is a Michanical Engineer with a Masters in Systems Control and Robotics and PhD in Machine Learning / Medical Science from Karolinska Institutet in Sweden.

2- Arman Vali (Co-founder & CEO): 12 years of experience in creating several fast-growing startups in collaboration with Rocket-Internet in the region. Arman is a Mechanical Engineer with MBA in marketing.

Initiative by

Supported by